{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:22:40Z","timestamp":1756383760006,"version":"3.44.0"},"reference-count":14,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,10,21]]},"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>Lung neuroendocrine tumours (Lung NETs) are a rare group of pulmonary neoplasms often characterised by insidious clinical behaviour. Lung NET account for ~1%\u20132% of all lung malignancies in adults and 30% of all NETs. Incidence ranges from 0.2 to 2\/100 000 population per year. While some patients may be asymptomatic, others may present with obstructive symptoms due to mass effect. Incidence of spontaneous pneumothorax as a complication of lung neoplasms is rare (0.05%\u20131.4% of all pneumothoraces). In this report, we present a case of recurrent pneumothorax due to Lung NET that was refractory to conservative management. We also discuss the diagnostic methods as well as surgical management approach, which is considered the treatment of choice in such tumours.<\/jats:p>","DOI":"10.1136\/bcr-2019-231083","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T06:15:41Z","timestamp":1573452941000},"page":"e231083","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Pulmonary carcinoid presenting with persistent pneumothorax"],"prefix":"10.1136","volume":"12","author":[{"given":"Kristina Camila","family":"Santiago-Naranjo","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Miami Miller School of Medicine at Holy Cross Hospital, Fort Lauderdale, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9407-9220","authenticated-orcid":false,"given":"Amro","family":"Ilaiwy","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, Duke University Hospital, Durham, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,11,10]]},"reference":[{"key":"2025082700343984000_12.11.e231083.1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012272314550"},{"key":"2025082700343984000_12.11.e231083.2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11105"},{"key":"2025082700343984000_12.11.e231083.3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011015)92:8<2204::AID-CNCR1564>3.0.CO;2-R"},{"key":"2025082700343984000_12.11.e231083.4","unstructured":"Lloyd RV , Osamura RY , Kl\u00f6ppel G , et al , eds. WHO classification of tumours of endocrine organs. International Agency for Research on Cancer, 2017."},{"key":"2025082700343984000_12.11.e231083.5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23883"},{"key":"2025082700343984000_12.11.e231083.6","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202870","article-title":"Atypical presentation of typical carcinoid","volume":"2014","author":"El-Kersh","year":"2014","journal-title":"BMJ Case Rep"},{"key":"2025082700343984000_12.11.e231083.7","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2006.08.005"},{"key":"2025082700343984000_12.11.e231083.8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23542"},{"key":"2025082700343984000_12.11.e231083.9","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31829f097a"},{"key":"2025082700343984000_12.11.e231083.10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.6.1647"},{"key":"2025082700343984000_12.11.e231083.11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"2025082700343984000_12.11.e231083.12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/curroncol13020006","article-title":"Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian national carcinoid expert group","volume":"13","author":"Maroun","year":"2006","journal-title":"Curr Oncol"},{"key":"2025082700343984000_12.11.e231083.13","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e31828e34a4"},{"key":"2025082700343984000_12.11.e231083.14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10120510","article-title":"Management of typical and atypical pulmonary carcinoids based on different established guidelines","volume":"10","author":"Gosain","year":"2018","journal-title":"Cancers"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-231083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:34:48Z","timestamp":1756280088000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-231083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":14,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,10]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/bcr-2019-231083"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-231083","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}